Coreline Soft
코어라인소프트 · 384470
Information Technology Software · KOSDAQ
Market cap US$37.2M (₩51.3B)
Overview
Coreline Soft makes AI-powered software that automatically analyses CT scan images to help doctors detect conditions such as lung cancer, chronic obstructive pulmonary disease, and coronary artery calcification, reducing the manual measurement work specialists would otherwise perform by hand.
Its products are used by hospitals and medical institutions, with a growing presence across North America, Europe, and Asia in addition to its home market. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company distributes through both direct sales and a network of domestic and international partners, as well as global medical-device sales platforms.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$3M
- FY2024US$2.8M
- FY2025US$3.1M
Operating profit
- FY2023−US$8.4M
- FY2024−US$10M
- FY2025−US$9.7M
Net income
- FY2023−US$10.2M
- FY2024−US$10.2M
- FY2025−US$10.5M
Key ratios (FY2025)
Why it matters
Coreline Soft has established European subsidiaries and secured lung-cancer screening contracts in Germany, Italy, and a six-country European consortium, giving it a direct international commercial footprint.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?